Lonsec launches personalised advice capability


Lonsec is capitalising on a mismatch between the industry’s focus on investment objectives and the capacity of tools to provide personalised solutions, upgrading its iRate platform with a new solution for tailored advice, according to chief executive, Matt Olsen.
Lonsec’s ratings platform for the assessment of the suitability of products for certain investors, BIOmetrics, would now be able to be used to build and assess portfolios or Approved Product Lists (APLs), and integrated with iRate.
Olsen said a challenge had arisen in the industry to match increased demand from investors for personalised platforms.
“Building solutions around these objectives can be a daunting process,” he said.
“They may want to invest ethically, reduce their portfolio’s complexity, or manage different types of risk.”
The combined functionality of BIOmetrics’ ratings and the iRate construction tool aimed to create a more seamless search for financial products, based on their ratings outcome across a range of BIOmetrics factors. It would also scan portfolios and APLs to assess performance.
Olsen said investors could see suggestions for similar financial products which also had strong alignment to their chosen BIOmetrics factors.
Recommended for you
Lonsec and SQM Research have highlighted manager selection as a crucial risk for financial advisers when it comes to private market investments, particularly due to the clear performance dispersion.
Macquarie Asset Management has indicated its desire to commit the fast-growing wealth business in Australia by divesting part of its public investment business to Japanese investment bank Nomura.
Australia’s “sophisticated” financial services industry is a magnet for offshore fund managers, according to a global firm.
The latest Morningstar asset manager survey believes ETF providers are likely to retain the market share they have gained from active managers.